Bcl-3 Promotes TNF-induced Hepatocyte Apoptosis by Regulating the Deubiquitination of RIP1

Yiming Hu,Haohao Zhang,Ningxia Xie,Dandan Liu,Yuhang Jiang,Zhi Liu,Deji Ye,Sanhong Liu,Xi Chen,Cuifeng Li,Qi Wang,Xingxu Huang,Yongzhong Liu,Yufang Shi,Xiaoren Zhang
DOI: https://doi.org/10.1038/s41418-021-00908-7
IF: 12.067
2021-01-01
Cell Death and Differentiation
Abstract:Tumor necrosis factor-α (TNF) is described as a main regulator of cell survival and apoptosis in multiple types of cells, including hepatocytes. Dysregulation in TNF-induced apoptosis is associated with many autoimmune diseases and various liver diseases. Here, we demonstrated a crucial role of Bcl-3, an IκB family member, in regulating TNF-induced hepatic cell death. Specifically, we found that the presence of Bcl-3 promoted TNF-induced cell death in the liver, while Bcl-3 deficiency protected mice against TNF/D-GalN induced hepatoxicity and lethality. Consistently, Bcl-3-depleted hepatic cells exhibited decreased sensitivity to TNF-induced apoptosis when stimulated with TNF/CHX. Mechanistically, the in vitro results showed that Bcl-3 interacted with the deubiquitinase CYLD to synergistically switch the ubiquitination status of RIP1 and facilitate the formation of death-inducing Complex II. This complex further resulted in activation of the caspase cascade to induce apoptosis. By revealing this novel role of Bcl-3 in regulating TNF-induced hepatic cell death, this study provides a potential therapeutic target for liver diseases caused by TNF-related apoptosis.
What problem does this paper attempt to address?